Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ramot at Tel Aviv University Ltd.

Latest From Ramot at Tel Aviv University Ltd.

Pacts In Medtech, July/August 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in July and August 2017.

Deals Pacts in Medtech

Recent Tech Transfer Deals (10/2011)

Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.

BioLineRx licenses compound for neuropathic and inflammatory pain

Jerusalem-based BioLineRx has signed a worldwide, exclusive licence agreement with Ramot, the technology transfer arm of Tel Aviv University, in order to gain access to the early-stage compound BL-7050, an orally available molecule for neuropathic and inflammatory pain. Financial terms were not disclosed.


Cell-Based Solutions for Neurologic Disease

Emerging tissue-engineering and cell transplantation therapies have the potential to provide solutions to many of the treatment challenges facing neurologists today.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Academic and Research Institutions
  • Other Names / Subsidiaries
    • Tel Aviv University